What blood tests are used for arthritis screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Blood Tests for Arthritis Screening

The essential blood tests for arthritis screening include complete blood count (CBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA), antinuclear antibodies (ANA), and liver function tests. 1, 2

Core Laboratory Tests for Arthritis Screening

Inflammatory Markers

  • ESR and CRP
    • Should be performed at baseline for both diagnosis and prognosis 1
    • Indicate ongoing inflammation but are not specific to any particular type of arthritis 2
    • Should be repeated when clinically relevant 1

Autoantibodies

  • Rheumatoid Factor (RF) and Anti-CCP (ACPA)

    • Must be tested in all patients with suspected inflammatory arthritis 1
    • Anti-CCP: 67-78.5% sensitivity, 95-98% specificity (highest specificity for RA) 2
    • RF: 69-84% sensitivity, 78-85% specificity (higher sensitivity but lower specificity than Anti-CCP) 2
    • Negative tests do not exclude progression to RA 1
  • Antinuclear Antibodies (ANA)

    • Should be considered if systemic connective tissue disease is suspected 2
    • Less specific for RA, more relevant for other autoimmune conditions 2

Basic Laboratory Panel

  • Complete Blood Count (CBC)

    • Essential baseline investigation before establishing diagnosis 1
    • Helps exclude other causes of joint symptoms 1
  • Liver Function Tests

    • Transaminases should be checked to exclude other diseases 1
    • Important baseline before potential DMARD therapy 2
  • Urinalysis

    • Recommended as part of the basic screening panel 1

Additional Tests Based on Clinical Suspicion

  • HLA-B27

    • Not routinely recommended 1
    • May be helpful in specific clinical settings (e.g., suspected spondyloarthropathy) 1
  • Additional Autoantibody Tests

    • Consider if connective tissue disease/systemic inflammatory disorder is suspected 1
    • May include antibodies to extractable nuclear antigens, anti-dsDNA 1
  • Thyroid Function Tests

    • Can help rule out thyroid disorders that can present with joint pain 2

Imaging Studies to Complement Blood Tests

  • X-rays of affected joints

    • Should be performed at baseline 1, 2
    • X-rays of hands, wrists, and feet should be considered as presence of erosions predicts development of RA 1
  • Ultrasound and MRI

    • Not recommended for routine use 1
    • MRI of hands and wrists could be considered when RA is suspected 1, 2

Diagnostic Algorithm

  1. Initial Screening: Order CBC, ESR, CRP, RF, anti-CCP, liver function tests, and urinalysis for all patients with suspected inflammatory arthritis
  2. Based on Clinical Features:
    • If small joint involvement predominates: Focus on RF and anti-CCP
    • If systemic symptoms present: Add ANA testing
    • If axial symptoms predominate: Consider HLA-B27
  3. Interpret Results in Clinical Context:
    • Positive RF and/or anti-CCP with elevated inflammatory markers strongly suggests RA
    • Negative autoantibodies with elevated inflammatory markers may indicate seronegative arthritis
    • Positive ANA may suggest connective tissue disease

Common Pitfalls to Avoid

  • Overreliance on a single test can lead to misdiagnosis 2
  • Negative RF and anti-CCP do not exclude RA diagnosis 2
  • Elevated inflammatory markers can occur in various conditions including infections and malignancies 2
  • Delayed referral to a rheumatologist (should be within 6 weeks of symptom onset) 1, 2

Remember that laboratory tests should be interpreted in the context of clinical findings, as no single test can definitively diagnose or exclude inflammatory arthritis.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Rheumatologic Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.